MENU

ARVN Arvinas Forecast, Technical & Fundamental Analysis

a developer of therapies to degrade disease-causing proteins

Industry Biotechnology
ARVN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
ARVN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I. Advisor
published Earnings

ARVN is expected to report earnings to rise 15.46% to -112 cents per share on August 06

Arvinas ARVN Stock Earnings Reports
Q2'24
Est.
$-1.12
Q1'24
Beat
by $0.43
Q4'23
Missed
by $1.34
Q3'23
Beat
by $0.40
Q2'23
Beat
by $0.40
The last earnings report on May 07 showed earnings per share of -97 cents, beating the estimate of -139 cents. With 216.85K shares outstanding, the current market capitalization sits at 2.02B.
A.I. Advisor
published General Information

General Information

a developer of therapies to degrade disease-causing proteins

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
395 Winchester Avenue
Phone
+1 203 535-1456
Employees
445
Web
https://www.arvinas.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CSVIX35.980.35
+0.98%
Calvert Small-Cap I
ARTKX49.330.19
+0.39%
Artisan International Value Investor
PORIX61.00N/A
N/A
Trillium ESG Global Equity Institutional
FMIFX21.83N/A
N/A
FMI International II Ccy UnH Ins
CTSIX33.30-0.16
-0.48%
Calamos Timpani Small Cap Growth I

ARVN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ARVN has been loosely correlated with ABCL. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ARVN jumps, then ABCL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARVN
1D Price
Change %
ARVN100%
+2.25%
ABCL - ARVN
49%
Loosely correlated
+2.99%
AXON - ARVN
46%
Loosely correlated
-0.73%
VCYT - ARVN
46%
Loosely correlated
+1.41%
IPSC - ARVN
44%
Loosely correlated
-0.42%
CRBU - ARVN
44%
Loosely correlated
+7.96%
More